Results 131 to 140 of about 956 (195)
A Modeling Study for Hip Fracture Rates in Romania. [PDF]
Moldovan F, Moldovan L.
europepmc +1 more source
PARATHYROID CANCER: REVIEW OF UNCOMMON DISEASE. [PDF]
Yabanoglu H, Arer IM, Ozarslan F.
europepmc +1 more source
Biphosphonate Loaded PLGA (50:50) Microspheres for Implantation in Osteolysis
Çalış, Sema +3 more
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Renal handling of biphosphonate alendronate in rats
Biopharmaceutics and Drug Disposition, 1999Alendronate is a bisphosphonate that is secreted via a saturable pathway in rat kidney. This study is designed to discover if the rate-determining step in its net renal secretion is uptake into the renal tubule. The tissue uptake clearance of alendronate by the kidney, estimated from an integration plot analysis and normalized with respect to plasma ...
Yukio Kato, Jiunn H Lin, Y Sugiyama
exaly +3 more sources
Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management
Sixteen patients with jaw biphosphonate-osteonecrosis and with exposed bone areas were subdivided into 2 treatment groups. The first group (7 patients) underwent superficial or radical surgical therapy, while the second (9 patients) underwent antibiotic ...
Davide Bartolomeo Gissi +1 more
exaly +1 more source
Biphosphonate related osteonecrosis of the jaws
H. Geha, J.-M. Peron
openaire +2 more sources
The Effect of Biphosphonate on Induced Heterotopic Bone
Clinical Orthopaedics and Related Research, 1991HEBP (1-hydroxy, ethylidene-1, 1-biphosphonate) inhibited mineralization and was observed in matrix-induced heterotopic bone in rabbits. In one group of rabbits, HEBP was administered continuously until sacrifice 20 weeks after the operation. Another group of animals received HEBP for the first four weeks only.
H P, Hu +4 more
openaire +2 more sources
Implants and biphosphonates: 2012 guidelines for practitioners
Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale, 2013Revue de Stomatologie, de Chirurgie Maxillo-Faciale et de Chirurgie Orale - Vol. 114 - N° 1 - p.
openaire +3 more sources
[Biphosphonates and intraocular inflammation].
Archivos de la Sociedad Espanola de Oftalmologia, 2004PURPOSE/MATERIAL AND METHOD: A 67 year old woman had been taking oral alendronate in a single weekly dose of 70 mg. She developed panuveitis in her right eye and anterior uveitis in the left. The uveitis was resolved with steroids and discontinuation of alendronate. Three weeks later alendronate was reinstituted and this produced a recurrence. Her past
V M, Asensio Sánchez +2 more
openaire +1 more source

